Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Direct ✕HDFC Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseHDFCHDFC
NAV₹23.6750₹16.4070
NAV date20 Nov 202620 Nov 2026
History3.1 years4.0 years
Expense ratio1.1%1.1%
Stars★★★★★★★★★★
Growth Score94.5050.50

Returns

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
1 month+12.97%+7.69%
3 months+7.13%+1.91%
6 months+17.84%+11.83%
YTD+33.73%+7.72%
1 year+32.20%+5.98%
3 years (CAGR)+30.70%+12.01%
5 years (CAGR)——
10 years (CAGR)——
Since launch+31.83%+13.24%

Risk

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
Volatility15.8%15.5%
Downside volatility8.5%10.3%
Sharpe1.530.36
Sortino2.860.53
Calmar2.060.67
Return / risk1.950.78
Deepest fall−14.91%−18.04%
Days to recover126133
Below its high+0.00%+0.00%

Against benchmark

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
Alpha+7.54%+0.41%
Beta0.970.92
R²85.0%90.6%
Up capture108.9%95.3%
Down capture71.0%92.0%
Tracking error6.1%4.9%
Information ratio1.17−0.01
Treynor0.240.05

Consistency

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
Best 1-year+67.01%+39.99%
Middle 1-year+23.25%+6.68%
Worst 1-year+1.71%−6.17%
1-year periods with a loss0.0%9.1%
Middle 3-year+30.22%+12.75%
Positive months72.2%61.1%
Best day+3.18%+4.12%
Worst day−3.61%−6.25%
Worst 5% day−1.51%−1.52%
Positive days58.3%54.9%
NAVs a year247247

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR+27.71%+8.57%
1-year XIRR+41.37%+15.07%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth